NLS Pharmaceutics AG (NLSP) Income Annual - Discounting Cash Flows
NLSP
NLS Pharmaceutics AG
NLSP (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
Report Filing 2025-10-06 2025-05-16 2024-05-15 2023-05-05 2022-03-24 2021-05-14 2019-12-31 2018-12-31 2017-12-31
Revenue 0 0 0 0 0 0 0 0 0
Cost of Revenue -0 0.003 0.011 0.011 0.01 0 0 0 0
Gross Profit 0 -0.003 -0.011 -0.011 -0.01 0 0 0 0
Operating Expenses 4.11 4.38 11.8 15.47 11.85 2.3 4.2 0.003 5.77
Research & Development 0.293 0.422 5.91 8.98 5.92 0.1 1.7 0.001 4.32
Selling, General and Administrative 3.07 3.21 5.9 6.49 5.93 2.2 2.49 0.003 1.44
Other Operating Expenses 0.746 0.741 -0.011 -0 -0 0 0 0 0
Operating Income -4.11 -4.38 -11.81 -15.48 -11.86 -2.3 -4.2 -0.003 -5.77
Net Non-Operating Interest -0.063 -0.15 -0.145 -0.101 -0.068 -0.233 -0.819 -0.001 -0.89
Interest Income 0 0 0 0 0 0 0.001 0 0.001
Interest Expense 0.063 0.15 0.145 0.101 0.068 0.234 0.82 0.001 0.89
Equity & Other Income/(Expense) 2 2.55 -0.22 -0.913 -0.017 -0.329 -0.431 -0.001 -0.001
Income Before Tax -2.17 -1.98 -12.17 -16.5 -11.95 -2.86 -5.45 -0.005 -6.66
Income Tax Expense 0 0 0 0 0 0 0 0 -0.006
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0.006
Net Income -2.17 -1.98 -12.17 -16.5 -11.95 -2.86 -5.45 -0.005 -6.66
Depreciation and Amortization -0 0.003 0.011 0.011 0.01 0 4.2 0.003 5.77
EBITDA -4.11 -4.38 -11.8 -15.47 -11.85 -2.3 -0 0 0
Earnings Per Share (EPS) -36.8 -26.3 -3.2 -8.4 -8.1 -5.9 -4.9 -329.9 -5.7
Diluted Earnings Per Share -20.4 -26.3 -3.2 -8.4 -8.1 -5.9 -4.9 -329.9 -5.7
Weighted Average Shares Outstanding 0.4 0.075 3.82 1.97 1.47 0.482 1.11 0 1.18
Diluted Weighted Average Shares Outstanding 0.4 0.154 3.82 1.97 1.47 0.482 1.11 0 1.18
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program